Outcomes of a Comprehensive, Pharmacist-Managed Injectable Anticoagulation Discharge Program for the Prophylaxis and Treatment of Venous Thromboembolism

被引:2
|
作者
Reger, Melissa A. [1 ]
Chapman, Jamie L. [2 ]
Lutomski, Dave M. [3 ,4 ]
Mueller, Eric W. [4 ,5 ]
机构
[1] Community Reg Med Ctr, Dept Pharm, Burn Surg, Fresno, CA USA
[2] Blount Mem Hosp, Dept Pharm Serv, Internal Med, Maryville, TN 37804 USA
[3] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Surg Trauma, Cincinnati, OH USA
[4] Univ Cincinnati, Clin Pharm, Div Pharm Practice, James L Winkle Coll Pharm, Cincinnati, OH USA
[5] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Crit Care, Cincinnati, OH USA
关键词
D O I
10.1177/875512251102700502
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Safe and effective transition of patients receiving injectable anticoagulation, from an inpatient to an outpatient setting, requires patient education, prescription coordination, and appropriate follow-up. Objective: To evaluate a long-standing, hospital-wide, pharmacist-managed injectable anticoagulation discharge program at an urban academic medical center. Methods: This observational study included adults discharged on an injectable anticoagulant between December 1, 2008, and February 28, 2009. The primary endpoint was program adherence, defined as percent of discharged patients whose anticoagulation therapy was coordinated by a pharmacist. Secondary endpoints included duration of patient counseling and medication procurement (including confirmation of current home supply or need for complete procurement of a full/new prescription); length of hospital stay for patients with a primary diagnosis of venous thromboembolism (VTE); and VTE recurrence and bleeding rates at 3 months. Descriptive statistics were used and are presented as proportions and mean (SD). Results: A total of 207 patients discharged on an injectable anticoagulant (3.2 discharges/day) were included. Pharmacist coordination was documented for 180 (87%) patients. Overall, pharmacists spent 37.6 (25.5) minutes per patient, including 19.4 (9.6) minutes for counseling and 19.7 (19.7) minutes for medication procurement; 150 (83%) patients required complete medication procurement lasting 21.4 (19.6) minutes. The length of hospital stay for patients with a primary diagnosis of VTE was 3.2 (2.4) days. At 3 months, 5.3% and 1.4% of assessable patients had recurrent VTE or major bleeding events, respectively. Patients with major bleeding experienced intracranial hemorrhage (n = 2) and gastrointestinal bleeding (n = 1), all beyond the first 2 weeks after discharge. Conclusions: The pharmacist-managed injectable anticoagulation discharge program was completed in a large proportion of patients. Patient education and medication procurement require the majority of time-related resources. Continual process improvement is crucial for hospitals to ensure that all patients discharged with injectable anticoagulation are assessed and receive anticoagulation education.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 48 条
  • [32] Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization
    Fratoni, Andrew J.
    Kois, Abigail K.
    Colmerauer, Jessica L.
    Linder, Kristin E.
    Nicolau, David P.
    Kuti, Joseph L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [33] Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes
    Penning-van Beest, Fernie J. A.
    Overbeek, Jetty A.
    Meijer, Willemijn M.
    Woodruff, Kimberly
    Jackson, Joseph
    van der Vis, Harm
    van der Linden, Paul
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (09) : 972 - 978
  • [34] Long-term anticoagulation for the treatment and secondary prophylaxis of venous thromboembolism among men with prostate cancer in Sweden: risk of recurrent venous thromboembolism and major bleeding
    Brobert, G.
    Farahmand, B.
    Stattin, P.
    Garmo, H.
    Balabanova, Y.
    THROMBOSIS RESEARCH, 2021, 200 : S40 - S40
  • [35] A pharmacist-managed medication adherence program to improve antiretroviral therapy adherence and clinical outcomes in HIV/AIDS-infected adults and children.
    Chung, AM
    Mancao, N
    PHARMACOTHERAPY, 2005, 25 (03): : 479 - 479
  • [36] Discharge Pharmacological Prophylaxis and 90-Day Outcomes for Venous Thromboembolism After Hip and Knee Replacements in Older Adults
    Ko, Darae
    Kapoor, Alok
    Rose, Adam
    Hanchate, Amresh
    Miller, Donald
    Winter, Michael
    Palmisano, Joseph
    Henault, Lori
    Tripodis, Yorghos
    Karcz, Anita
    Hylek, Elaine
    CIRCULATION, 2017, 136
  • [37] Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration
    Perino, Alexander C.
    Fan, Jun
    Schmitt, Susan
    Guo, Jennifer D.
    Hlavacek, Patrick
    Din, Natasha
    Kothari, Mitra
    Pundi, Krishna
    Russ, Cristina
    Emir, Birol
    Turakhia, Mintu P.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (11): : E008005
  • [38] Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
    Yanina Balabanova
    Bahman Farahmand
    Pär Stattin
    Hans Garmo
    Gunnar Brobert
    BMC Urology, 22
  • [39] Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
    Balabanova, Yanina
    Farahmand, Bahman
    Stattin, Par
    Garmo, Hans
    Brobert, Gunnar
    BMC UROLOGY, 2022, 22 (01)
  • [40] Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance
    Kline, Jeffrey A.
    Kahler, Zachary P.
    Beam, Daren M.
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 561 - 569